nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—periosteum—sarcoma	0.0852	0.336	CbGeAlD
Ibandronate—FDPS—myometrium—sarcoma	0.018	0.0708	CbGeAlD
Ibandronate—FDPS—seminal vesicle—sarcoma	0.0162	0.064	CbGeAlD
Ibandronate—FDPS—hematopoietic system—sarcoma	0.0154	0.0608	CbGeAlD
Ibandronate—FDPS—connective tissue—sarcoma	0.0149	0.0586	CbGeAlD
Ibandronate—FDPS—smooth muscle tissue—sarcoma	0.0136	0.0536	CbGeAlD
Ibandronate—FDPS—skin of body—sarcoma	0.0134	0.0529	CbGeAlD
Ibandronate—FDPS—cardiac atrium—sarcoma	0.0117	0.0462	CbGeAlD
Ibandronate—FDPS—uterus—sarcoma	0.0117	0.0459	CbGeAlD
Ibandronate—FDPS—lymphoid tissue—sarcoma	0.0109	0.0428	CbGeAlD
Ibandronate—FDPS—tendon—sarcoma	0.0102	0.0403	CbGeAlD
Ibandronate—FDPS—bone marrow—sarcoma	0.00989	0.039	CbGeAlD
Ibandronate—FDPS—testis—sarcoma	0.00845	0.0333	CbGeAlD
Ibandronate—FDPS—liver—sarcoma	0.00799	0.0315	CbGeAlD
Ibandronate—FDPS—lymph node—sarcoma	0.00613	0.0242	CbGeAlD
Ibandronate—Decreased appetite—Vincristine—sarcoma	0.00111	0.00148	CcSEcCtD
Ibandronate—Blood creatinine increased—Epirubicin—sarcoma	0.0011	0.00148	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Vincristine—sarcoma	0.0011	0.00147	CcSEcCtD
Ibandronate—Fatigue—Vincristine—sarcoma	0.0011	0.00147	CcSEcCtD
Ibandronate—Dyspepsia—Mitoxantrone—sarcoma	0.00109	0.00146	CcSEcCtD
Ibandronate—Hypertension—Etoposide—sarcoma	0.00109	0.00146	CcSEcCtD
Ibandronate—Pain—Vincristine—sarcoma	0.00109	0.00146	CcSEcCtD
Ibandronate—Constipation—Vincristine—sarcoma	0.00109	0.00146	CcSEcCtD
Ibandronate—Osteoarthritis—Doxorubicin—sarcoma	0.00109	0.00146	CcSEcCtD
Ibandronate—Pain in extremity—Doxorubicin—sarcoma	0.00109	0.00146	CcSEcCtD
Ibandronate—Decreased appetite—Mitoxantrone—sarcoma	0.00108	0.00145	CcSEcCtD
Ibandronate—Chest pain—Etoposide—sarcoma	0.00108	0.00144	CcSEcCtD
Ibandronate—Abdominal pain upper—Epirubicin—sarcoma	0.00108	0.00144	CcSEcCtD
Ibandronate—Migraine—Doxorubicin—sarcoma	0.00107	0.00144	CcSEcCtD
Ibandronate—Fatigue—Mitoxantrone—sarcoma	0.00107	0.00143	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00107	0.00143	CcSEcCtD
Ibandronate—Discomfort—Etoposide—sarcoma	0.00106	0.00143	CcSEcCtD
Ibandronate—Breast disorder—Epirubicin—sarcoma	0.00106	0.00143	CcSEcCtD
Ibandronate—Pain—Mitoxantrone—sarcoma	0.00106	0.00142	CcSEcCtD
Ibandronate—Constipation—Mitoxantrone—sarcoma	0.00106	0.00142	CcSEcCtD
Ibandronate—Hypersensitivity—Thiotepa—sarcoma	0.00106	0.00142	CcSEcCtD
Ibandronate—Nasopharyngitis—Epirubicin—sarcoma	0.00105	0.00141	CcSEcCtD
Ibandronate—Face oedema—Doxorubicin—sarcoma	0.00105	0.00141	CcSEcCtD
Ibandronate—Hypersensitivity—Dactinomycin—sarcoma	0.00105	0.00141	CcSEcCtD
Ibandronate—Gastrointestinal pain—Vincristine—sarcoma	0.00104	0.0014	CcSEcCtD
Ibandronate—Gastritis—Epirubicin—sarcoma	0.00104	0.0014	CcSEcCtD
Ibandronate—Anaphylactic shock—Etoposide—sarcoma	0.00103	0.00138	CcSEcCtD
Ibandronate—Asthenia—Thiotepa—sarcoma	0.00103	0.00138	CcSEcCtD
Ibandronate—Infection—Etoposide—sarcoma	0.00103	0.00137	CcSEcCtD
Ibandronate—Asthenia—Dactinomycin—sarcoma	0.00102	0.00137	CcSEcCtD
Ibandronate—Feeling abnormal—Mitoxantrone—sarcoma	0.00102	0.00137	CcSEcCtD
Ibandronate—Blood creatinine increased—Doxorubicin—sarcoma	0.00102	0.00137	CcSEcCtD
Ibandronate—Influenza—Epirubicin—sarcoma	0.00102	0.00136	CcSEcCtD
Ibandronate—Asthma—Epirubicin—sarcoma	0.00102	0.00136	CcSEcCtD
Ibandronate—Dysphagia—Epirubicin—sarcoma	0.00102	0.00136	CcSEcCtD
Ibandronate—Pruritus—Thiotepa—sarcoma	0.00102	0.00136	CcSEcCtD
Ibandronate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00102	0.00136	CcSEcCtD
Ibandronate—Abdominal pain—Vincristine—sarcoma	0.00101	0.00135	CcSEcCtD
Ibandronate—Body temperature increased—Vincristine—sarcoma	0.00101	0.00135	CcSEcCtD
Ibandronate—Skin disorder—Etoposide—sarcoma	0.001	0.00134	CcSEcCtD
Ibandronate—Hyperhidrosis—Etoposide—sarcoma	0.000998	0.00134	CcSEcCtD
Ibandronate—Abdominal pain upper—Doxorubicin—sarcoma	0.000995	0.00133	CcSEcCtD
Ibandronate—Urticaria—Mitoxantrone—sarcoma	0.000986	0.00132	CcSEcCtD
Ibandronate—Breast disorder—Doxorubicin—sarcoma	0.000985	0.00132	CcSEcCtD
Ibandronate—Diarrhoea—Thiotepa—sarcoma	0.000984	0.00132	CcSEcCtD
Ibandronate—Abdominal pain—Mitoxantrone—sarcoma	0.000981	0.00131	CcSEcCtD
Ibandronate—Body temperature increased—Mitoxantrone—sarcoma	0.000981	0.00131	CcSEcCtD
Ibandronate—Bronchitis—Epirubicin—sarcoma	0.000979	0.00131	CcSEcCtD
Ibandronate—Diarrhoea—Dactinomycin—sarcoma	0.000976	0.00131	CcSEcCtD
Ibandronate—Nasopharyngitis—Doxorubicin—sarcoma	0.000975	0.00131	CcSEcCtD
Ibandronate—Gastritis—Doxorubicin—sarcoma	0.000965	0.00129	CcSEcCtD
Ibandronate—Dizziness—Thiotepa—sarcoma	0.000951	0.00127	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Epirubicin—sarcoma	0.000946	0.00127	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—sarcoma	0.000942	0.00126	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—sarcoma	0.000942	0.00126	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—sarcoma	0.000942	0.00126	CcSEcCtD
Ibandronate—Hypersensitivity—Vincristine—sarcoma	0.000939	0.00126	CcSEcCtD
Ibandronate—Paraesthesia—Etoposide—sarcoma	0.000927	0.00124	CcSEcCtD
Ibandronate—Weight decreased—Epirubicin—sarcoma	0.000921	0.00123	CcSEcCtD
Ibandronate—Hypersensitivity—Mitoxantrone—sarcoma	0.000915	0.00123	CcSEcCtD
Ibandronate—Asthenia—Vincristine—sarcoma	0.000915	0.00123	CcSEcCtD
Ibandronate—Vomiting—Thiotepa—sarcoma	0.000914	0.00122	CcSEcCtD
Ibandronate—Pneumonia—Epirubicin—sarcoma	0.000913	0.00122	CcSEcCtD
Ibandronate—Infestation NOS—Epirubicin—sarcoma	0.000908	0.00122	CcSEcCtD
Ibandronate—Infestation—Epirubicin—sarcoma	0.000908	0.00122	CcSEcCtD
Ibandronate—Vomiting—Dactinomycin—sarcoma	0.000907	0.00122	CcSEcCtD
Ibandronate—Rash—Thiotepa—sarcoma	0.000907	0.00121	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—sarcoma	0.000906	0.00121	CcSEcCtD
Ibandronate—Dermatitis—Thiotepa—sarcoma	0.000906	0.00121	CcSEcCtD
Ibandronate—Headache—Thiotepa—sarcoma	0.000901	0.00121	CcSEcCtD
Ibandronate—Rash—Dactinomycin—sarcoma	0.0009	0.00121	CcSEcCtD
Ibandronate—Decreased appetite—Etoposide—sarcoma	0.000898	0.0012	CcSEcCtD
Ibandronate—Renal failure—Epirubicin—sarcoma	0.000892	0.0012	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Etoposide—sarcoma	0.000892	0.00119	CcSEcCtD
Ibandronate—Asthenia—Mitoxantrone—sarcoma	0.000891	0.00119	CcSEcCtD
Ibandronate—Fatigue—Etoposide—sarcoma	0.00089	0.00119	CcSEcCtD
Ibandronate—Stomatitis—Epirubicin—sarcoma	0.000885	0.00119	CcSEcCtD
Ibandronate—Pain—Etoposide—sarcoma	0.000883	0.00118	CcSEcCtD
Ibandronate—Constipation—Etoposide—sarcoma	0.000883	0.00118	CcSEcCtD
Ibandronate—Urinary tract infection—Epirubicin—sarcoma	0.000882	0.00118	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000875	0.00117	CcSEcCtD
Ibandronate—Diarrhoea—Vincristine—sarcoma	0.000872	0.00117	CcSEcCtD
Ibandronate—Sweating—Epirubicin—sarcoma	0.00087	0.00117	CcSEcCtD
Ibandronate—Hepatobiliary disease—Epirubicin—sarcoma	0.000858	0.00115	CcSEcCtD
Ibandronate—Nausea—Thiotepa—sarcoma	0.000854	0.00114	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—sarcoma	0.000852	0.00114	CcSEcCtD
Ibandronate—Feeling abnormal—Etoposide—sarcoma	0.000851	0.00114	CcSEcCtD
Ibandronate—Diarrhoea—Mitoxantrone—sarcoma	0.00085	0.00114	CcSEcCtD
Ibandronate—Nausea—Dactinomycin—sarcoma	0.000848	0.00114	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—sarcoma	0.000845	0.00113	CcSEcCtD
Ibandronate—Gastrointestinal pain—Etoposide—sarcoma	0.000844	0.00113	CcSEcCtD
Ibandronate—Dizziness—Vincristine—sarcoma	0.000843	0.00113	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—sarcoma	0.00084	0.00113	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—sarcoma	0.00084	0.00113	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—sarcoma	0.000826	0.00111	CcSEcCtD
Ibandronate—Urticaria—Etoposide—sarcoma	0.00082	0.0011	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—sarcoma	0.000819	0.0011	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—sarcoma	0.000819	0.0011	CcSEcCtD
Ibandronate—Body temperature increased—Etoposide—sarcoma	0.000816	0.00109	CcSEcCtD
Ibandronate—Abdominal pain—Etoposide—sarcoma	0.000816	0.00109	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—sarcoma	0.000816	0.00109	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—sarcoma	0.000815	0.00109	CcSEcCtD
Ibandronate—Vomiting—Vincristine—sarcoma	0.000811	0.00109	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—sarcoma	0.000809	0.00108	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—sarcoma	0.000805	0.00108	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—sarcoma	0.000805	0.00108	CcSEcCtD
Ibandronate—Rash—Vincristine—sarcoma	0.000804	0.00108	CcSEcCtD
Ibandronate—Dermatitis—Vincristine—sarcoma	0.000803	0.00108	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—sarcoma	0.000803	0.00108	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—sarcoma	0.000801	0.00107	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—sarcoma	0.000799	0.00107	CcSEcCtD
Ibandronate—Headache—Vincristine—sarcoma	0.000799	0.00107	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—sarcoma	0.000794	0.00106	CcSEcCtD
Ibandronate—Vomiting—Mitoxantrone—sarcoma	0.000789	0.00106	CcSEcCtD
Ibandronate—Rash—Mitoxantrone—sarcoma	0.000783	0.00105	CcSEcCtD
Ibandronate—Dermatitis—Mitoxantrone—sarcoma	0.000782	0.00105	CcSEcCtD
Ibandronate—Headache—Mitoxantrone—sarcoma	0.000778	0.00104	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—sarcoma	0.000761	0.00102	CcSEcCtD
Ibandronate—Hypersensitivity—Etoposide—sarcoma	0.000761	0.00102	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—sarcoma	0.000758	0.00102	CcSEcCtD
Ibandronate—Nausea—Vincristine—sarcoma	0.000757	0.00101	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—sarcoma	0.000756	0.00101	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—sarcoma	0.000754	0.00101	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—sarcoma	0.000748	0.001	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—sarcoma	0.000745	0.000998	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—sarcoma	0.000743	0.000995	CcSEcCtD
Ibandronate—Asthenia—Etoposide—sarcoma	0.000741	0.000993	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—sarcoma	0.000741	0.000993	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—sarcoma	0.000739	0.00099	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—sarcoma	0.000739	0.00099	CcSEcCtD
Ibandronate—Nausea—Mitoxantrone—sarcoma	0.000737	0.000988	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—sarcoma	0.000736	0.000986	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—sarcoma	0.000734	0.000984	CcSEcCtD
Ibandronate—Chills—Epirubicin—sarcoma	0.000731	0.00098	CcSEcCtD
Ibandronate—Pruritus—Etoposide—sarcoma	0.000731	0.000979	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—sarcoma	0.00072	0.000965	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—sarcoma	0.000714	0.000956	CcSEcCtD
Ibandronate—Erythema—Epirubicin—sarcoma	0.000709	0.00095	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—sarcoma	0.000709	0.00095	CcSEcCtD
Ibandronate—Diarrhoea—Etoposide—sarcoma	0.000707	0.000947	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—sarcoma	0.000705	0.000944	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—sarcoma	0.0007	0.000937	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—sarcoma	0.000699	0.000936	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—sarcoma	0.000695	0.000931	CcSEcCtD
Ibandronate—Back pain—Epirubicin—sarcoma	0.000686	0.000919	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—sarcoma	0.000684	0.000916	CcSEcCtD
Ibandronate—Dizziness—Etoposide—sarcoma	0.000683	0.000915	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—sarcoma	0.000682	0.000914	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—sarcoma	0.000681	0.000912	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—sarcoma	0.000679	0.00091	CcSEcCtD
Ibandronate—Chills—Doxorubicin—sarcoma	0.000676	0.000906	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—sarcoma	0.000666	0.000893	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—sarcoma	0.000661	0.000885	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—sarcoma	0.000658	0.000882	CcSEcCtD
Ibandronate—Vomiting—Etoposide—sarcoma	0.000657	0.00088	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—sarcoma	0.000656	0.000879	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—sarcoma	0.000656	0.000879	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—sarcoma	0.000656	0.000878	CcSEcCtD
Ibandronate—Rash—Etoposide—sarcoma	0.000651	0.000872	CcSEcCtD
Ibandronate—Dermatitis—Etoposide—sarcoma	0.000651	0.000872	CcSEcCtD
Ibandronate—Headache—Etoposide—sarcoma	0.000647	0.000867	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—sarcoma	0.000647	0.000866	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—sarcoma	0.000643	0.000861	CcSEcCtD
Ibandronate—Malaise—Epirubicin—sarcoma	0.00064	0.000857	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—sarcoma	0.000637	0.000854	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—sarcoma	0.000635	0.000851	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—sarcoma	0.000631	0.000845	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—sarcoma	0.000627	0.00084	CcSEcCtD
Ibandronate—Nausea—Etoposide—sarcoma	0.000613	0.000822	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—sarcoma	0.000612	0.00082	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—sarcoma	0.000609	0.000816	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—sarcoma	0.000607	0.000813	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—sarcoma	0.000604	0.000809	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—sarcoma	0.000604	0.000809	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—sarcoma	0.000604	0.000809	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—sarcoma	0.000602	0.000806	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.0006	0.000803	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—sarcoma	0.000597	0.000799	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—sarcoma	0.000592	0.000793	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—sarcoma	0.000591	0.000791	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—sarcoma	0.00059	0.00079	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—sarcoma	0.00058	0.000777	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—sarcoma	0.000579	0.000776	CcSEcCtD
Ibandronate—Infection—Epirubicin—sarcoma	0.000575	0.000771	CcSEcCtD
Ibandronate—Shock—Epirubicin—sarcoma	0.00057	0.000763	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—sarcoma	0.000568	0.000761	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—sarcoma	0.000567	0.000759	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—sarcoma	0.000562	0.000753	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—sarcoma	0.00056	0.00075	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—sarcoma	0.000559	0.000749	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—sarcoma	0.000559	0.000749	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—sarcoma	0.000559	0.000749	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—sarcoma	0.000557	0.000746	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000555	0.000743	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—sarcoma	0.000552	0.00074	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—sarcoma	0.000546	0.000732	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—sarcoma	0.000536	0.000718	CcSEcCtD
Ibandronate—Infection—Doxorubicin—sarcoma	0.000532	0.000713	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000527	0.000707	CcSEcCtD
Ibandronate—Shock—Doxorubicin—sarcoma	0.000527	0.000706	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—sarcoma	0.000525	0.000704	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—sarcoma	0.000524	0.000701	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—sarcoma	0.00052	0.000697	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—sarcoma	0.00052	0.000696	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—sarcoma	0.000518	0.000694	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—sarcoma	0.00051	0.000683	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—sarcoma	0.000503	0.000674	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—sarcoma	0.0005	0.00067	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—sarcoma	0.000499	0.000669	CcSEcCtD
Ibandronate—Pain—Epirubicin—sarcoma	0.000495	0.000663	CcSEcCtD
Ibandronate—Constipation—Epirubicin—sarcoma	0.000495	0.000663	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000488	0.000654	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—sarcoma	0.000484	0.000649	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—sarcoma	0.000481	0.000644	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—sarcoma	0.000477	0.000639	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—sarcoma	0.000473	0.000634	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—sarcoma	0.000472	0.000632	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—sarcoma	0.000466	0.000624	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000462	0.00062	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—sarcoma	0.000462	0.000619	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—sarcoma	0.00046	0.000616	CcSEcCtD
Ibandronate—Pain—Doxorubicin—sarcoma	0.000458	0.000614	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—sarcoma	0.000458	0.000614	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—sarcoma	0.000458	0.000613	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—sarcoma	0.000458	0.000613	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—sarcoma	0.000441	0.000591	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000438	0.000587	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—sarcoma	0.000427	0.000571	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—sarcoma	0.000426	0.00057	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—sarcoma	0.000423	0.000567	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—sarcoma	0.000423	0.000567	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—sarcoma	0.000415	0.000556	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—sarcoma	0.00041	0.000549	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—sarcoma	0.000396	0.000531	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—sarcoma	0.000395	0.000529	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—sarcoma	0.000384	0.000515	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—sarcoma	0.000383	0.000513	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—sarcoma	0.000379	0.000508	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—sarcoma	0.000368	0.000493	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—sarcoma	0.000366	0.000491	CcSEcCtD
Ibandronate—Rash—Epirubicin—sarcoma	0.000365	0.000489	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—sarcoma	0.000365	0.000489	CcSEcCtD
Ibandronate—Headache—Epirubicin—sarcoma	0.000363	0.000486	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—sarcoma	0.000354	0.000475	CcSEcCtD
Ibandronate—Nausea—Epirubicin—sarcoma	0.000344	0.000461	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—sarcoma	0.000341	0.000456	CcSEcCtD
Ibandronate—Rash—Doxorubicin—sarcoma	0.000338	0.000452	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—sarcoma	0.000337	0.000452	CcSEcCtD
Ibandronate—Headache—Doxorubicin—sarcoma	0.000336	0.00045	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—sarcoma	0.000318	0.000426	CcSEcCtD
